Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Severe pediatric alopecia areata worsens quality of life for patients and families.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Hydroxychloroquine may help treat alopecia areata in children.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

PRP and cell therapies may help with hair loss, but more research is needed.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

UV light causes skin color loss in bald areas; wear a cap and use sunscreen.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.